This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Mar 11;82(10):824-5.

doi: 10.1212/WNL.0000000000000197. Epub 2014 Feb 7.

Feasibility of Huntington disease trials in the disease prodrome

Elizabeth A McCusker¹, Richard H Myers

Affiliations

Affiliation

¹ From the Department of Neurology (E.A.M.), Westmead Hospital, and Sydney Medical School, University of Sydney, Australia; and Department of Neurology (R.H.M), Genome Science Institute, Boston University School of Medicine, Boston, MA.

PMID: 24510495
DOI: 10.1212/WNL.0000000000000197

Editorial

Feasibility of Huntington disease trials in the disease prodrome

Elizabeth A McCusker et al. Neurology. 2014.

. 2014 Mar 11;82(10):824-5.

doi: 10.1212/WNL.0000000000000197. Epub 2014 Feb 7.

Authors

Elizabeth A McCusker¹, Richard H Myers

Affiliation

¹ From the Department of Neurology (E.A.M.), Westmead Hospital, and Sydney Medical School, University of Sydney, Australia; and Department of Neurology (R.H.M), Genome Science Institute, Boston University School of Medicine, Boston, MA.

PMID: 24510495
DOI: 10.1212/WNL.0000000000000197

No abstract available

PubMed Disclaimer

Comment on

PRECREST: a phase II prevention and biomarker trial of creatine in at-risk Huntington disease.
Rosas HD, Doros G, Gevorkian S, Malarick K, Reuter M, Coutu JP, Triggs TD, Wilkens PJ, Matson W, Salat DH, Hersch SM. Rosas HD, et al. Neurology. 2014 Mar 11;82(10):850-7. doi: 10.1212/WNL.0000000000000187. Epub 2014 Feb 7. Neurology. 2014. PMID: 24510496 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

R01 NS073947/NS/NINDS NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information